Export to

• Google Calendar
• iCalendar file
• hCalendar markup
  <div class="vevent h-event"> <h1 class="summary p-name">OBA: Insights for Succeeding in Bioscience</h1> <div class='date'><time class="dtstart dt-start" title="2009-01-28T07:30:00" datetime="2009-01-28T07:30:00">Wednesday, January 28, 2009 from 7:30</time>–<time class="dtend dt-end" title="2009-01-28T09:00:00" datetime="2009-01-28T09:00:00">9am</time></div> <div class="location vcard p-location h-card"> <a class="url" href='http://calagator.org/venues/202390947'><span class='fn org p-name'>Schwabe, Williamson, & Wyatt</span></a> <div class="adr p-adr h-adr"> <div class="street-address p-street-address">1211 Sw 5th Ave</div> <span class="locality p-locality">Portland</span> , <span class="region p-region">OR</span> <span class="postal-code p-postal-code">97204</span> <div class="country-name p-country-name">US</div> (<a href='https://maps.google.com/maps?q=1211%20Sw%205th%20Ave,%20Portland%20OR%2097204%20US'>map</a>) </div> </div> <div class="description p-description"> <p>This highly interactive discussion will focus on current challenges and market conditions that impact the bioscience and pharmaceutical industries. The intent is to learn how to better cope and prosper in uncertain times. During this session, the audience will have the opportunity to ask questions. Our guest panel, moderated by Paul Abel from Blue Research, includes the following members:</p> <p>Peter Smith is Director of Strategic Development at Biotronik Inc, a medical device company specializing in Cardiac Rhythm Management. Peter has an international background in healthcare marketing and strategy, having worked for Hoffmann la Roche and McKinsey. Peter earned an MBA at MIT Sloan and a Masters in Health Technology from the MIT-Harvard Institute of Health Science and Technology.</p> <p>William Newman is managing director at Northwest Technology Ventures, a $14 million Oregon seed fund focused on technology-based startups and spin-offs from the research sector in both life sciences and technology. Prior to joining the research faculty at MIT, Bill earned a Ph.D. in mechanical engineering and applied mathematics at Ecole Polytechnique in France, and an MBA from MIT’s Sloan School of Management.</p> <p>Lewis Nashner was the founder of Neurocom International, Inc. until it was acquired by Natus Biomedical, Inc. in 2008. Prior to founding Neurocom, Lew was a Senior Scientist at the RS Dow Neurological Sciences Institute of the Oregon Health and Sciences University, serving as the Institute’s Chairman. Lew received the B.S. and M.S. degrees in Aeronautical and Astronautical engineering from MIT. He also received the Sc.D. degree in Biomedical Engineering and Neuroscience from MIT.</p> </div> <h3>Links</h3> <ul> <li><a class="url u-url" href="http://www.oregonbio.org/bioForumJanuary2009/">Website</a></li> </ul> </div>